ID   KAL-1
AC   CVCL_QY03
DR   Wikidata; Q54899462
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1913659;
RX   PubMed=8320183;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=1913659).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=1913659;
RA   Ichinose, Ichiro
RA   Nakano, Shuji
RA   Ohshima, Ko-ichi
RA   Mitsugi, Kenji
RA   Anzai, Keizo
RA   Shida, Toshihiko
RA   Niho, Yoshiyuki
RT   "Establishment of Epstein-Barr virus-negative diffuse large cell
RT   lymphoma cell line with an 8;22 chromosomal translocation.";
RL   Cancer Res. 51:5392-5397(1991).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=8320183; DOI=10.1007/BF02633962;
RA   Ichinose, Ichiro
RA   Nakano, Shuji
RA   Esaki, Taito
RA   Koga, Tatsuhiko
RA   Mitsugi, Kenji
RA   Yamada, Hidenori
RA   Niho, Yoshiyuki
RT   "Growth modulation of human tumor cells by a growth-inhibiting
RT   activity derived from tumorigenic V79 Chinese hamster cells.";
RL   In Vitro Cell. Dev. Biol. Anim. 29:332-338(1993).
//